KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

about

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity.

P2860

Q38631484-5087D896-B67B-4F89-82F6-CA7E532DA93E

P2860

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q36819651

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

@en

type

Item

label

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

@en

prefLabel

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

@en

P1476

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

@en

P2093

Hai Yang

http://www.w3.org/2001/XMLSchema#string

Jia-Jie Hao

http://www.w3.org/2001/XMLSchema#string

Jian Cao

http://www.w3.org/2001/XMLSchema#string

Ming-Rong Wang

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Yan Cai

http://www.w3.org/2001/XMLSchema#string

Yan-Yi Jiang

http://www.w3.org/2001/XMLSchema#string

Yi-Zhen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.

Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases

Cancer statistics, 2015

Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I-IIIA

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

Gene expression-based classification of non-small cell lung carcinomas and survival prediction

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

P2888

srep24786

P304

24786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24786

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27098511

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4838871

http://www.w3.org/2001/XMLSchema#string

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

about

P2860

P2860

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P921

P932